🇺🇸 FDA

Drug profile · INN

latanoprost

APO-LATANOPROST

FDA: approved EMA: approved TGA: approved S01EE01
US status
approved
Patents linked
0
News articles
0

Quick answer

latanoprost (APO-LATANOPROST) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.

Key facts

INN latanoprost
Brand APO-LATANOPROST
Route OPHTHALMIC
Formulation EMULSION
ATC code S01EE01
Originator Alphapharm Pty Ltd

Frequently asked questions

What is latanoprost?

latanoprost (APO-LATANOPROST) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.

What is the brand name for latanoprost?

APO-LATANOPROST is a marketed brand name for latanoprost. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of latanoprost?

latanoprost has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.